Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Parkinson's disease | R-HSA-1643685 | 0 | tomatidine | 5831 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | tomatidine | 5831 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | tomatidine | 5831 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | tomatidine | 5831 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | tomatidine | 5831 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | papaverine | 4680 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | papaverine | 4680 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | papaverine | 4680 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | papaverine | 4680 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | papaverine | 4680 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | tetrahydroalstonine | 72340 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | tetrahydroalstonine | 72340 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | tetrahydroalstonine | 72340 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | tetrahydroalstonine | 72340 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | tetrahydroalstonine | 72340 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | tetrahydroalstonine | 72340 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | tetrahydroalstonine | 72340 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | tetrahydroalstonine | 72340 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | tetrahydroalstonine | 72340 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | arecoline | 2733526 | drug-path |